Vaccines (Oct 2024)

Truncated VZV gE Induces High-Titer Neutralizing Antibodies in Mice

  • Jiehui Wu,
  • Hai Li,
  • Yanping Yuan,
  • Ruichen Wang,
  • Tianxin Shi,
  • Ziyi Li,
  • Qianqian Cui,
  • Shihong Fu,
  • Kai Nie,
  • Fan Li,
  • Qikai Yin,
  • Jiayi Du,
  • Huanyu Wang,
  • Songtao Xu

DOI
https://doi.org/10.3390/vaccines12101139
Journal volume & issue
Vol. 12, no. 10
p. 1139

Abstract

Read online

Backgrounds: A contemporary public health challenge is the increase in the prevalence rates of herpes zoster (HZ) worldwide. Methods: In this work, the gE gene structure was analyzed using bioinformatics techniques, and three plasmids of varying lengths, tgE537, tgE200, and tgE350, were expressed in Chinese hamster ovary (CHO) cells. These proteins were used to immunize BALB/c mice with Al/CpG adjuvant; ELISPOT and FCM were used to evaluate cellular immunity; and ELISA, VZV microneutralization, and FAMA assays were performed to detect antibody titers. Results: Target protein concentrations of 1.8 mg/mL for tgE537, 0.15 mg/mL for tgE200 and 0.65 mg/mL for tgE350 were effectively produced. The ability of the three protein segments to stimulate CD4+ and CD8+ T cells, as well as to cause lymphocytes to secrete IFN-γ and IL-4, did not significantly differ from one another. Both tgE537 and tgE350 were capable of generating VZV-specific antibodies and neutralizing antibodies, while tgE350 had the highest neutralizing antibody titer (4388). There was no equivalent humoral immune response induced by tgE200. Conclusions: The results of this investigation provide the groundwork for the creation of HZ recombinant vaccines using truncated proteins as antigens.

Keywords